Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 14.91 |
| PEG Ratio (TTM) | N/A | 3.53 |
| P/S Ratio (TTM) | N/A | 3.67 |
| P/B Ratio (TTM) | N/A | 6.18 |
| P/FCF Ratio (TTM) | N/A | 8.61 |
| Price to 5YR AVG Earnings Ratio | 23.04 | 26.53 |
| Price to 5YR AVG FCF Ratio | 12.06 | -22.47 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 2.78% |
| ROE (TTM) | N/A | 45.48% |
| Net Profit Margin (TTM) | N/A | 28.90% |
| ROIC 5YR AVG | 3.66% | 23.94% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -122.65% | 188.39% | 52.67% |
| Revenue | -6.57% | 192.60% | 96.67% |
| Net Income | -123.56% | 187.04% | 92.64% |
| Cash Flow | -95.75% | 472.86% | 343.60% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.79 | 1.09 |
| Quick Ratio (TTM) | -0.07 | 0.29 |
| D/E Ratio (TTM) | 0.34 | 0.70 |
| Interest Coverage (TTM) | N/A | 22.52 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.11 | 0.76 |
| LTL to 5YR AVG FCF | 3.08 | -2.16 |
| Shares Outstanding Growth 5YR AVG | -19.11% | 30.37% |